BeStock  
Stocks › Biotechnology › PBLS

Parabilis Medicines PBLS

US equityMarket cap rank #2333Biotechnology
$27.44 −$0.19 (-0.67%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $27.44 0.00%
Open$27.07
Prev close$27.63
Day range$26.50 – $28.52
Volume1.25M
Market cap$3.44B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts4
Average target$41.33+50.6% vs. price
  • Buy 100%
Low $39.00Now $27.44Avg $41.33High $45.00

Recent rating changes

The last 16 actions on file set price targets from $39.00 to $45.00, averaging $41.31.

DateFirmRatingTarget
13 Nov 2026 CCORF BUY $39.00
13 Nov 2026 H.C. Wainwright BUY $40.00
9 Nov 2026 CCORF BUY $39.00
26 Oct 2026 BofA Securities BUY $45.00
26 Oct 2026 Evercore BUY –
26 Oct 2026 H.C. Wainwright BUY $40.00
22 Oct 2026 H.C. Wainwright BUY $40.00
16 Sep 2026 BofA Securities BUY $45.00
14 Aug 2026 BofA Securities BUY –
14 Aug 2026 Guggenheim BUY $40.00
13 Aug 2026 LifeSci Capital BUY $42.00
18 Jul 2026 LifeSci Capital BUY $42.00
6 Jul 2026 BofA Securities BUY $45.00
6 Jul 2026 Evercore BUY –
6 Jul 2026 Leerink Partners BUY $40.00
5 Jul 2026 Guggenheim BUY $40.00

Discussion

No comments yet — be the first to weigh in on PBLS.

Sign in to join the discussion.

Scroll to Top